Business1 min read

Cipla subsidiary clears USFDA inspection

By · Published by Everything Blog

In short

Cipla, a subsidiary of Cipla Limited, has cleared a routine inspection by the US Food and Drug Administration (USFDA), verifying its compliance with stringent standards for international markets. This achievement is a crucial step in maintaining high quality and safety standards, enhancing Cipla's reputation, and positioning the company for future growth in the international market.

Key points

  • Cipla successfully completed a routine inspection by the USFDA.: Cipla successfully completed a routine inspection by the USFDA.
  • This clearance ensures compliance with stringent standards for international markets.: This clearance ensures compliance with stringent standards for international markets.
  • The inspection was conducted to verify the company's manufacturing facilities' adherence…: The inspection was conducted to verify the company's manufacturing facilities' adherence to FDA guidelines.

Sources checked by our analysis pipeline: 1

(More to come)

(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

Subscribe to The Economic Times Prime and read the ET ePaper online.

(Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.)

Subscribe to The Economic Times Prime and read the ET ePaper online.

Original source: economictimes.indiatimes.com

Business